정규장
로그인 회원가입
CVS
CVS Health Corp
7월 27일 9:37 AM ET (한국 7/27 22:37)
$107.74
+0.85 ▲ +0.80%

씨브이에스 헬스(CVS) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$137.5B
미드캡
P/E
47.3
적정 수준
배당수익률
2.50%
52주 위치
94%
저점 +84% · 고점 -3%
애널리스트
매수
D
Fundamental health
vs. Healthcare 대형주
수익성
Top 80%
성장
Top 58%
밸류에이션
Top 66%
재무 안정
Top 77%
💰 Is this stock pricier than usual right now?
Compared to this company's own recent 5년 (not other companies).
Very cheap
Cheap
Typical
Pricey
🔥 Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 47원. Over the past 5년, it usually traded around 17원. Earnings have also shrunk, which lifts the multiple — one of the priciest stretches of the past 5년.
Pricy doesn't mean bad — it means expectations are already baked in.
Index S&P 500P/E 47.31EPS (ttm) 2.28Insider Own 0.16%Shs Outstand 1.28BPerf Week 0.25%
Market Cap 137.47BForward P/E 12.78EPS next Y 13.2%Insider Trans -62.77%Shs Float 1.27BPerf Month 5.76%
Enterprise Value 204.18BPEG 1EPS next Q 1.85Inst Own 89.17%Short Float 1.57%Perf Quarter 36.62%
Income 2.93BP/S 0.34EPS this Y 10.36%Inst Trans -1.07%Short Ratio 2.39Perf Half Y 30.31%
Sales 407.94BP/B 1.77EPS next 5Y 12.79%ROA 1.15%Short Interest 19.94MPerf YTD 35.76%
Book/sh 60.85P/C 11.63EPS past 3/5Y -24.7% -23.94%ROE 3.8%52W High -2.66% ($110.68)Perf Year 83.39%
Cash/sh 9.26P/FCF 18.59Sales past 3/5Y 7.6% 8.4%ROIC 1.94%52W Low 84.17% ($58.50)Perf 3Y 41.86%
Dividend Est. $2.69 (2.5%)EV/EBITDA 11.43EPS Y/Y TTM -45.09%Gross Margin 13.88%Volatility(W/M) 2.21% 2.36%Perf 5Y 29.39%
Dividend TTM 2.66EV/Sales 0.5Sales Y/Y TTM 7.68%Oper. Margin 3.26%ATR (14) 2.48Perf 10Y 11.59%
Dividend Ex-Date 2026/7/23Quick Ratio 0.66EPS Q/Q 63.49%Profit Margin 0.72%RSI (14) 61.42Recom 1.53
Dividend Gr. 3/5Y 5.74% 5.87%Current Ratio 0.87Sales Q/Q 6.17%SMA20 2.04% ($105.59)Beta 0.59Target Price $112.29
Payout 191.23%Debt/Eq 1.01Earnings 2026/8/5SMA50 7.64% ($100.09)Rel Volume 0.64Prev Close $106.89
Employees 300000LT Debt/Eq 0.95EPS/Sales Surpr. 17.7% 5.72%SMA200 28.49% ($83.85)Avg Volume(3M) 8.33MPrice $107.74
IPO 1952/10/1Option/Short Yes/YesTrades 46312Volume 5,368,042Change 0.8%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12*
25.3
25.6
25.9
25.12*
26.3
Revenue Net income 최근 분기: 매출 $100B (YoY +6%) · 순이익 $2.9B (YoY +65%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 CVS Health Corp (CVS) Investment Analysis

What kind of company is CVS Health Corp?

씨브이에스 헬스(CVS) 방어주
Healthcare · Healthcare Plans
Top 112 by Market Cap — Large-Cap

💊 An integrated healthcare company with a nationwide network of pharmacies and health clinics across the U.S., also operating prescription drug benefits management and health insurance (Aetna). Headquartered in Woonsocket, Rhode Island, its core strength lies in a vertically integrated model that combines pharmacies, drug pricing management, insurance, and primary care.

Learn more about CVS Health Corp →
Market Cap
$137B
Approx. KRW 188 trillion
⚖️ 47% of Samsung Electronics
Market Cap Rank112
Employees300,000people
IPO1952/10/01
Current Price$107.74 ≈ 147,604원
📌 S&P 500 · NYSE · USA

Key Events

⏰ Upcoming events
🔔 Earnings release D-9
예상 EPS $1.85
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🎯 Ex-div 2026년 7월 23일 (목) 주당 $0.665
🔔 Earnings release 2026년 5월 6일 (수) · 장 시작 전 EPS +17.7% 매출 +5.7%
🎯 Ex-div 2026년 4월 23일 (목)
🔔 Earnings release 2026년 2월 10일 (화) · 장 시작 전

Is it profitable?

Both profitability & finances need caution
Review management risk carefully before investing
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
3.3%
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 대형주 Median 16.8% · Bottom 23%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
0.7%
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 대형주 Median 10.1% · Bottom 24%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
13.9%
✓ 매우 부진
My positionBottom 5%
Low range Average High range
Healthcare 대형주 Median 62.1% · Bottom tier
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
3.8%
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 대형주 Median 11.9% · Bottom 25%
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
1.1%
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 대형주 Median 5.1% · Bottom 24%
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
1.9%
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 대형주 Median 7.4% · Bottom 25%
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
1.01
✓ Average
My positionMid-range
Low range Average High range
Healthcare 대형주 Median 0.66
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
0.87
✓ 매우 부진
My positionBottom 5%
Low range Average High range
Healthcare 대형주 Median 1.79
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.66
✓ 매우 부진
My positionBottom 5%
Low range Average High range
Healthcare 대형주 Median 1.40
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$112.29
현재가 대비 +4.2%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
12.78배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
PEG (성장 반영 밸류)
1.00
적정
💡 PEG 1~1.5 — 성장 대비 합리적
내년 EPS 예상 성장률
+13.2%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
+12.8%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Reliability
Beat estimates in 2 of the last 2 quarters
2
예상 상회
0
예상 부합
0
예상 하회
100%
상회 비율
+12.9%
평균 서프라이즈
2026.05.06
상회
실적 $2.57 · 예상 $2.21 +16.5%
2026.02.10
상회
실적 $1.09 · 예상 $1.00 +9.4%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Turnaround Expected
Past performance was weak, but the outlook is positive
Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+10.4%
양호
My positionMid-range
Low range Average High range
방어주 대형주 Median 9.6% · Top 44%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+13.2%
양호
My positionMid-range
Low range Average High range
방어주 대형주 Median 10.8% · Top 41%
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
+12.8%
우수
My positionTop 25%
Low range Average High range
방어주 대형주 Median 9.8% · Top 22%
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
-24.7%
매우 부진
My positionBottom 5%
Low range Average High range
방어주 대형주 Median 4.7% · Bottom tier
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
-23.9%
매우 부진
My positionBottom 5%
Low range Average High range
방어주 대형주 Median 4.1% · Bottom tier
Past 5-Year Revenue
How much revenue grew over the past 5 years
+8.4%
양호
My positionMid-range
Low range Average High range
방어주 대형주 Median 6.7% · Top 41%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+6.2%
평균
My positionMid-range
Low range Average High range
방어주 대형주 Median 8.4% · Bottom 40%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Long-term weakness — -39%p below the market
CVS +29.4% · S&P 500 +68.0%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-38.6%p
Significantly behind the market
vs Health Care (XLV)
+5.7%p
slightly ahead of the sector average
1-year basis
vs S&P 500
+66.9%p
well ahead of the market
vs Health Care (XLV)
+63.6%p
well ahead of the sector average
Current position within 52-week range
Low (-84.2%p) High (-2.7%p)
Current price is 84.2% above the 52-week low and 2.7% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-14.2%
Annualized volatility
29.8%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢
Current diagnosis · 2026-07-24
Uptrend zone

Current price $107.74 above the midline ($105.58). Normal upward flow. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡
Current diagnosis · 2026-07-24
Neutral zone — weak trend

MACD 2.479 · Signal 2.642 · Hist -0.162. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢
Current diagnosis · 2026-07-24
Bullish zone

RSI 61.4 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 64.7.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Assets·Vs. Sales·Vs. Cash Flow, In line with peers on Vs. Earnings
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Mid-range
🏢 Vs. Assets Cheap
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Cheap
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
47.31x
✓ Pricey
My positionBottom 25%
Low range Average High range
Healthcare 대형주 median 26.98x · Bottom 14% — expensive within the industry
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
12.78x
✓ Cheap
My positionMid-range
Low range Average High range
Healthcare 대형주 median 16.44x · Around the industry average
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
1.77x
✓ Very cheap
My positionTop 25%
Low range Average High range
Healthcare 대형주 median 3.93x · Top 16% — relatively cheap within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
0.34x
✓ Very cheap
My positionTop 5%
Low range Average High range
Healthcare 대형주 median 3.49x · Top 1% — relatively cheap within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
11.43x
✓ Cheap
My positionMid-range
Low range Average High range
Healthcare 대형주 median 13.79x · Around the industry average
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
18.59x
✓ Cheap
My positionMid-range
Low range Average High range
Healthcare 대형주 median 19.31x · Around the industry average
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$112.29 vs. current price +4.2%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Healthcare 대형주

Who owns it?

Ownership backdrop is unfavorable
Insider net selling -62.8% · Institutional net selling -1.1% · Short interest light 1.6%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-62.8%
Insiders large net selling
🏦 Institutions (funds & investors)
-1.1%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 89.2%
Institution-led, stable structure
Healthcare 대형주 Median 91.9%
🧑‍💼 Insiders 0.2%
Low, common among large-caps
Healthcare 대형주 Median 0.8%
👤 Retail investors (estimated) 10.7%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
1.6%
Low — limited short-side pressure
Healthcare 대형주 Median 3.6%
Past 89 days Little change
Short interest days to cover
2.4 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 1.28B주
Float (tradable shares) 1.27B주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 89 days.

ETFs holding CVS

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당주 — 연 2.5% 배당
5년 배당 성장률 5.87%
Dividend Yield
2.50%
Industry average 1.25%
Dividend Per Share
$2.69
Annualized
Payout Ratio
191%
Share of net income paid as dividends
5-Year Growth
5.9%
Annualized dividend growth
📅 지급월 1월 · 4월 · 10월
📊 총 이력 1985~2026 (167건)
연도별 배당 총액 추이
주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.
$1.70 +21.4%
2016
$2.00 +17.6%
2017
$2.00 +0.0%
2018
$2.00 +0.0%
2019
$2.00 +0.0%
2020
$2.00 +0.0%
2021
$2.20 +10.0%
2022
$2.42 +10.0%
2023
$2.66 +9.9%
2024
$2.66 +0.0%
2025
$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소
최근 배당 이력 총 167건
아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.
배당락일
주당 금액
지급일
당시 수익률
2026-04-23
$0.665
3.37%
2026-01-22
$0.665
4.02%
2025-10-23
$0.665
3.28%
2025-07-22
$0.665
5.44%
2025-04-22
$0.665
4.06%
2025-01-23
$0.665
4.94%
2024-10-21
$0.665
4.57%
2024-07-22
$0.665
4.46%
2024-04-19
$0.665
4.51%
2024-01-19
$0.665
4.21%
2023-10-19
$0.605
4.21%
2023-07-20
$0.605
3.89%
2023-04-20
$0.605
3.90%
2023-01-19
$0.605
3.21%
2022-10-20
$0.550
2.97%
2022-07-21
$0.550
2.84%
2022-04-21
$0.550
2.47%
2022-01-20
$0.550
2.49%
2021-10-21
$0.500
2.88%
2021-07-22
$0.500
3.03%
2021-04-22
$0.500
3.28%
2021-01-21
$0.500
3.37%
2020-10-21
$0.500
4.22%
2020-07-22
$0.500
3.92%
2020-04-22
$0.500
3.31%
2020-01-22
$0.500
3.38%
2019-10-23
$0.500
3.81%
2019-07-24
$0.500
4.47%
2019-04-22
$0.500
3.81%
2019-01-24
$0.500
3.08%
2018-10-23
$0.500
3.45%
2018-07-24
$0.500
3.05%
2018-04-20
$0.500
3.07%
2018-01-23
$0.500
2.49%
2017-10-23
$0.500
2.63%
2017-07-20
$0.500
2.49%
2017-04-19
$0.500
2.92%
2017-01-20
$0.500
2.18%
2016-10-20
$0.425
1.95%
2016-07-19
$0.425
2.04%
2016-04-20
$0.425
1.85%
2016-01-20
$0.425
1.94%
2015-10-20
$0.350
1.62%
2015-07-21
$0.350
1.20%
2015-04-22
$0.350
1.23%
2015-01-20
$0.350
1.47%
2014-10-21
$0.275
1.33%
2014-07-17
$0.275
1.68%
2014-04-17
$0.275
1.66%
2014-01-21
$0.275
1.72%
2013-10-17
$0.225
1.77%
2013-07-18
$0.225
1.64%
2013-04-19
$0.225
1.62%
2013-01-22
$0.225
1.37%
2012-10-18
$0.163
1.67%
2012-07-19
$0.163
1.63%
2012-04-19
$0.163
1.33%
2012-01-19
$0.163
1.55%
2011-10-19
$0.125
1.69%
2011-07-20
$0.125
1.49%
2011-04-19
$0.125
1.44%
2011-01-19
$0.125
1.38%
2010-10-20
$0.088
1.38%
2010-07-20
$0.088
1.36%
2010-04-21
$0.088
0.89%
2010-01-20
$0.088
1.16%
2009-10-20
$0.076
0.80%
2009-07-21
$0.076
0.90%
2009-04-20
$0.076
1.00%
2009-01-21
$0.076
1.04%
2008-10-17
$0.069
1.18%
2008-07-17
$0.069
0.80%
2008-04-17
$0.060
0.74%
2008-01-17
$0.060
0.78%
2007-10-18
$0.060
0.67%
2007-07-19
$0.060
0.69%
2007-04-20
$0.060
0.65%
2007-01-18
$0.049
0.63%
2006-10-18
$0.039
0.61%
2006-07-19
$0.039
0.59%
2006-04-20
$0.039
0.63%
2006-01-19
$0.039
0.67%
2005-10-19
$0.036
0.69%
2005-07-19
$0.036
0.57%
2005-04-20
$0.036
0.68%
2005-01-20
$0.036
0.58%
2004-10-20
$0.034
0.62%
2004-07-20
$0.033
0.59%
2004-04-21
$0.033
0.64%
2004-01-20
$0.034
0.84%
2003-10-17
$0.029
0.86%
2003-07-17
$0.029
1.05%
2003-04-17
$0.029
1.25%
2003-01-21
$0.029
0.94%
2002-10-17
$0.029
1.04%
2002-07-18
$0.029
1.11%
2002-04-19
$0.029
0.84%
2002-01-18
$0.029
1.04%
2001-10-18
$0.029
0.90%
2001-07-19
$0.029
0.72%
2001-04-20
$0.029
0.51%
2001-01-19
$0.029
0.53%
2000-10-19
$0.029
0.63%
2000-07-20
$0.029
0.53%
2000-04-20
$0.029
0.66%
2000-01-20
$0.029
0.86%
1999-10-20
$0.029
0.66%
1999-07-20
$0.029
0.59%
1999-04-21
$0.029
0.66%
1999-01-20
$0.029
0.58%
1998-10-21
$0.029
0.61%
1998-07-21
$0.029
0.55%
1998-04-21
$0.028
0.52%
1998-01-21
$0.028
0.46%
1997-10-21
$0.028
0.39%
1997-07-21
$0.007
11.76%
1997-04-21
$0.007
12.56%
1997-01-21
$0.007
14.70%
1996-10-21
$0.007
16.05%
1996-10-16
$1.48
17.34%
1996-07-19
$0.028
2.83%
1996-04-18
$0.028
2.48%
1996-01-19
$0.028
4.42%
1995-10-20
$0.095
4.42%
1995-07-20
$0.095
4.28%
1995-04-18
$0.095
5.33%
1995-01-18
$0.095
5.96%
1994-10-18
$0.095
5.53%
1994-07-19
$0.095
4.98%
1994-04-19
$0.095
4.81%
1994-01-18
$0.095
4.74%
1993-10-19
$0.095
4.22%
1993-07-20
$0.095
4.30%
1993-04-19
$0.095
4.23%
1993-01-19
$0.095
2.80%
1992-10-20
$0.092
2.98%
1992-07-20
$0.092
3.18%
1992-04-20
$0.092
2.99%
1992-01-14
$0.092
3.87%
1991-10-16
$0.090
3.98%
1991-07-17
$0.090
3.67%
1991-04-19
$0.090
3.40%
1991-01-15
$0.090
4.35%
1990-10-18
$0.089
4.97%
1990-07-17
$0.089
3.04%
1990-04-20
$0.089
2.89%
1990-01-16
$0.089
3.74%
1989-10-18
$0.081
3.13%
1989-07-18
$0.081
3.27%
1989-04-18
$0.081
3.52%
1989-01-17
$0.081
3.58%
1988-10-18
$0.066
3.42%
1988-07-19
$0.066
3.68%
1988-04-19
$0.066
3.57%
1988-01-19
$0.066
3.90%
1987-10-20
$0.055
3.67%
1987-07-20
$0.055
2.17%
1987-04-20
$0.055
2.47%
1987-01-20
$0.055
2.73%
1986-10-15
$0.049
3.21%
1986-07-17
$0.049
2.99%
1986-04-15
$0.049
3.01%
1986-01-17
$0.049
2.94%
1985-10-21
$0.045
3.16%
1985-07-17
$0.045
2.33%
1985-04-16
$0.045
1.70%
1985-01-16
$0.045
0.90%
* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.
💰 내가 100만원 투자한다면
연간 배당금 (세후) 2.1만원
5년 누적 (세후) 11.9만원
* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 5.87% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
CVS This Stock
$137.5B47.3 1.8 3.8% 2.5% +0.8%
LLY
$1.13T43.0 36.2 107.64% 0.58% +0.9%
JNJ
$634.1B30.5 7.5 25.74% 2.04% +1.6%
ABBV
$458.2B127.9 - 15221.82% 2.65% +0.9%
UNH
$382.1B27.1 3.9 12.49% 2.15% -0.7%
MRK
$323.7B36.9 7.1 18.97% 2.49% +0.5%
Sector Avg-25.82.7-48.83%1.25%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 씨브이에스 헬스(CVS)?

씨브이에스 헬스(CVS) belongs to the Healthcare sector and operates in the Healthcare Plans industry.

What is the market cap of CVS?

The market cap of CVS is approximately $137.5B, ranking 112 within its sector.

Does CVS pay dividends?

CVS has a dividend yield of approximately 2.50%, with an annual dividend of $2.69.

What is the P/E ratio of CVS?

CVS has a P/E ratio of approximately 47.3x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for CVS?

CVS has recorded a 52-week high of $110.68 and a low of $58.50.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.